Expression of B cell receptor-associated signaling molecules in human lupus

Autoimmunity

Volumn 33, Issue 3, 2001, Pages 213-224

  Huck, S ^a   Le Corre, R ^a   Youinou, P ^a   Zouali, M ^a  

^a HÔPITAL BROUSSAIS   (France)

Author keywords

B cell receptor; B cells; Human autoantibodies; Immune tolerance; SLE

Indexed keywords

AUTOANTIBODY; B LYMPHOCYTE RECEPTOR; CD22 ANTIGEN; CD45 ANTIGEN; PROTEIN KINASE LYN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; REGULATOR PROTEIN; SHP 1; SIGNAL PEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME REGULATION; FEEDBACK SYSTEM; FEMALE; FOLLOW UP; GLOMERULONEPHRITIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; LIFESPAN; MALE; METABOLIC DISORDER; METABOLIC REGULATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THYMUS;

EID: 0034911522     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.3109/08916930109008048     Document Type: Article

References (57)

1. Initiation and processing of signals from the B cell antigen receptor
2. Co-receptor and accessory regulation of B-cell antigen receptor signal transduction
3. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule
4. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice
5. CD19 regulates B lymphocyte signaling thresholds critical for the development of B-1 lineage cells and autoimmunity
6. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2
7. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice
8. Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice
9. Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45
10. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease
11. Hyperresponsive B cells in CD22-deficient mice
12. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice
13. CD22 is both a positive and negative regulator of B lymphocyte antigen receptor signal transduction: Altered signaling in CD22-deficient mice
14. CD22 is a negative regulator of B-cell receptor signalling
15. CD22 regulates thymus-independent responses and the lifespan of B cells
16. Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies
17. Common and individual features of the humoral immunity dysregulation of mice homozygous at the viable motheaten (mev) mutation
18. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene
19. Expression and catalytic activity of the tyrosine phosphatase PTP1C is severely impaired in motheaten and viable motheaten mice
20. Induction of autoimmunity in a transgenic model of B cell receptor peripheral tolerance: Changes in coreceptors and B cell receptor-induced tyrosine-phosphoproteins
21. B cells from patients with systemic lupus erythematosus display abnormal antigen receptor-mediated early signal transduction events
22. The 1982 revised criteria for the classification of systemic lupus erythematosus
23. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE
24. Restriction fragment length polymorphism analysis of the V kappa locus in human lupus
25. Induction of excessive B cell proliferation and differentiation by an in vitro stimulus in culture in human systemic lupus erythematosus
26. Tuning antigen receptor signaling by CD22: Integrating cues from antigens and the microenvironment
27. CD45: An emerging role as a protein tyrosine phosphatase required for lymphocyte activation and development
28. Protein tyrosine phosphatase 1C negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection
29. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation
30. Expression of the tyrosine kinase Lyn during B-cell receptor engagement and apoptosis
31. Spontaneous immunoglobulin A secretion and lack of mitogen-responsive B cells in systemic lupus erythematosus
32. Circulating and pokewed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus
33. Lymphocytotoxic antibodies in family members of patients with systemic lupus erythematosus
34. Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus and primary Sjogren's syndrome
35. Intrinsic B cell defects in NZB and NZW mice contribute to systemic lupus erythematosus in (NZB × NZW)F1 mice
36. B cell genotype determines the fine specificity of autoantibody in Ipr mice
37. Receptor editing, immune diversification and self-tolerance
38. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death
39. Downregulated expression of Shp-1 in burkitt-lymphomas and germinal center B lymphocytes
40. Identification of the gene variations in human CD22
41. Altered antigen receptor signaling and impaired Fas-mediated apoptosis of B cells in lyn-deficient mice
42. Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes
43. Inhibition of the B cell by CD22: A requirement for Lyn
44. A double-edged kinase Lyn: A positive and negative regulator for antigen receptor-mediated signals
45. Motheaten and viable motheaten mice have mutations in the haematopoietic cell phosphatase gene
46. Aberrant expression of the NF-kappaB and IkappaB proteins in B cells from viable motheaten mice
47. Spontaneous follicular exclusion of SHP1-deficient B cells is conditional on the presence of competitor wild-type B cells
48. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection
49. The motheaten mutation rescues B cell signaling and development in CD45-deficient mice
50. Reduced protein tyrosine phosphatase (PTPase) activity of CD45 on peripheral blood lymphocytes in patients with systemic lupus erythematosus (SLE)
51. TCR zeta chain lacking exon 7 in two patients with systemic lupus erythematosus
52. Autoantibodies specific for different isoforms of CD45 in systemic lupus erythematosus
53. Antibodies to the common leukocyte antigen (T200) inhibit an early phase in the activation of resting human B cells
54. Fidelity of T cell activation through multistep T cell receptor phosphorylation
55. DNA methylation: A potential pathway to abnormal autoreative lupus B cells
56. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
57. Abnormal DNA methylation and deoxycytosine-deoxyguanine content in nucleosomes from lymphocytes undergoing apoptosis